Page 117 - IMO-2-2
P. 117

Innovative Medicines & Omics                                            Modeling Aurora-B kinase inhibitors



               Drosophila Aurora kinase is oncogenic and amplified in      doi: 10.1002/cm.20039
               human colorectal cancers. EMBO J. 1998;17:3052-3065.
                                                               14.  Tang A, Gao K, Chu L, Zhang R, Yang J, Zheng J. Aurora
               doi: 10.1093/emboj/17.11.3052                      kinases: Novel therapy targets in cancers.  Oncotarget.
                                                                  2017;8(14):23937-23954.
            3.   Mahajan M, Sarkar A, Mondal S. Cell cycle protein BORA is
               associated with colorectal cancer progression by AURORA-     doi: 10.18632/oncotarget.14893
               PLK1 cascades: A bioinformatics analysis. J Cell Commun   15.  Jacobsen A, Bosch LJW, Kemp SRM, et al. Aurora kinase A
               Signal. 2023;17:773-791.
                                                                  (AURKA) interaction with Wnt and Ras-MAPK signalling
               doi: 10.1007/s12079-022-00719-6                    pathways in colorectal cancer. Sci Rep. 2018;8:7522.
            4.   Azeez KRA, Chatterjee S, Yu C, Golub TR, Sobott F,      doi: 10.1038/s41598-018-24982-z
               Elkins JM. Structural mechanism of synergistic activation   16.  Kanagasabai T, Venkatesan T, Natarajan U, et al. Regulation
               of  Aurora  kinase  B/C  by  phosphorylated  INCENP.  Nat   of cell cycle by MDM2 in prostate cancer cells through
               Commun. 2019;10(1):3166.                           Aurora Kinase-B and p21WAF1/CIP1 mediated pathways.
               doi: 10.1038/s41467-019-11085-0                    Cell Signal. 2020;66:109435.
            5.   Nguyen AL, Schindler K. Specialize and divide (Twice):      doi: 10.1016/j.cellsig.2019.109435
               Functions of three aurora kinase homologs in mammalian   17.  Samimi H, Haghpanah V, Irani S,  et al. Transcript-level
               oocyte meiotic maturation. Trends Genet. 2017;33(5):349-363.
                                                                  regulation of MALAT1-mediated cell cycle and apoptosis
               doi: 10.1016/j.tig.2017.03.005                     genes using dual MEK/Aurora kinase inhibitor “BI-847325”
                                                                  on anaplastic thyroid carcinoma.  DARU J Pharm Sci.
            6.   Marumoto T, Zhang D, Saya H. Aurora-A-a guardian of   2019;27(1):1-7.
               poles. Nat Rev Cancer. 2005;5(1):42-50.
                                                                  doi: 10.1007/s40199-018-0231-3
               doi: 10.1038/nrc1526
                                                               18.  Noor S, Choudhury A, Raza A, et al. Probing baicalin as
            7.   Carmena M, Earnshaw WC. The cellular geography of
               aurora kinases. Nat Rev Mol Cell Biol. 2003;4:842-854.  potential inhibitor of Aurora kinase B: A step towards lung
                                                                  cancer therapy. Int J Biol Macromol. 2024;258:128813.
               doi: 10.1038/nrm1245
                                                                  doi: 10.1016/j.ijbiomac.2023.128813
            8.   Dutertre S, Descamps S, Prigent C. On the role of aurora-A   19.  Huang D, Huang Y, Huang Z, Weng J, Zhang S, Gu W.
               in centrosome function. Oncogene. 2002;21(40):6175-6183.
                                                                  Relation of AURKB over-expression to low survival rate in
               doi: 10.1038/sj.onc.1205775                        BCRA and reversine-modulated Aurora-B kinase in breast
                                                                  cancer cell lines. Cancer Cell Int. 2019;19:166.
            9.   Tsai MY, Wiese C, Cao K, et al. A ran signalling pathway
               mediated by the mitotic kinase Aurora A in spindle assembly.      doi: 10.1186/s12935-019-0885-z
               Nat Cell Biol. 2003;5(3):242-248.
                                                               20.  Morahan BJ, Abrie C, Al-Hasani K,  et  al. Human aurora
               doi: 10.1038/ncb936                                kinase inhibitor hesperadin reveals epistatic interaction
                                                                  between plasmodium falciparum PfArk1 and PfNek1
            10.  Murata-Hori M, Tatsuka M, Wang YL. Probing the dynamics
               and functions of Aurora-B kinase in living cells during   kinases. Commun Biol. 2020;3(1):701.
               mitosis and cytokinesis. Mol Biol Cell. 2002;13(4):1099-1108.     doi: 10.1038/s42003-020-01424-z
               doi: 10.1091/mbc.01-09-0467                     21.  Kollareddy M, Zheleva D, Džubák P,  et al. Identification
                                                                  and characterization of drug resistance mechanisms in
            11.  Kimura M, Matsuda Y, Yoshioka T, Sumi N, Okano Y.
               Identification and characterization of STK12/Aik2: A   cancer cells against Aurora kinase inhibitors CYC116 and
               human gene related to aurora of Drosophila and yeast IPL1.   ZM447439. bioRxiv. 2020.
               Cytogenet Cell Genet. 1998;82(3-4):147-152.        doi: 10.1101/2020.08.26.268128
               doi: 10.1159/000015089                          22.  Martens S, Goossens V, Devisscher L, et al. RIPK1-dependent
                                                                  cell death: A  novel target of the Aurora kinase inhibitor
            12.  Gassmann R, Carvalho A, Henzing AJ,  et al. Borealin: A
               novel chromosomal passenger required for stability of the   Tozasertib (VX-680). Cell Death Dis. 2018;9(2):211.
               bipolar mitotic spindle. J Cell Biol. 2004;166(2):179-191.     doi: 10.1038/s41419-017-0245-7
               doi: 10.1083/jcb.200404001                      23.  Ajay Kumar TV, Anand SAA, Loganathan C, Saravanan K,
            13.  Sasai K, Katayama H, Stenoien DL, et al. Aurora-C kinase   Kabilan S, Parthasarathy V. Design, 3D QSAR modeling and
               is a novel chromosomal passenger protein that can   docking of TGF-β type I inhibitors to target cancer. Comput
               complement Aurora-B kinase function in mitotic cells. Cell   Biol Chem. 2018;76:232-244.
               Motil Cytoskeleton. 2004;59(4):249-263.            doi: 10.1016/j.compbiolchem.2018.07.011


            Volume 2 Issue 2 (2025)                        111                               doi: 10.36922/imo.6547
   112   113   114   115   116   117   118   119   120   121   122